Loading ...
TTR Amyloidosis - associated cardiomyopathy ( ATTR - CM ) , caused by TTR amyloid infiltration of the myocardium and conduction systemresultsin a restrictive cardiomyopathy associated with atrial arrhythmias , progressive heart failure with preserved ejection fraction in early phases
a factorcontributingto heart failure with preserved ejection fraction in patients with atrial fibrillation
Impaired myocardial relaxationresultingin diastolic dysfunction [ i.e. , Heart failure with preserved ejection fraction ( HFpEF
any clinical benefitresultingfrom stem cell therapy for heart failure with reduced ejection fraction
first(passive) was ... discoveredDiastolic Heart Failure Overview Historical Perspective Heart failure with preserved ejection fraction
Impaired myocardial oxygen availabilitycontributesto abnormal exercise hemodynamics in heart failure with preserved ejection fraction
important mechanismscontributingto the development of heart failure with preserved ejection fraction
more pronounced diastolic dysfunctionmay contributeto their greater predisposition for heart failure with preserved ejection fraction
Systolic HF ... weakened ventricular contractionsresultin heart failure with reduced ejection fraction ( HFrEF
Impaired cardiac relaxationalso contributesto a form of heart failure termed heart failure with preserved ejection fraction
NO ) availabilitymay contributeto the pathophysiology of heart failure with preserved ejection fraction ( HFpEF
the world 's first transcatheter devicedesignedto treat heart failure with preserved ejection fraction
myocardial systolic dysfunction with LV diastolic dysfunctioncould leadto heart failure with preserved ejection fraction ( HFpEF
ventricular diastolic dysfunctionleadingto heart failure with preserved ejection fraction ( HFpEF
diastolic dysfunctionleadingto heart failure with preserved ejection fraction ( HFpEF
left ventricular ( LV ) diastolic dysfunctionleadingto heart failure with preserved ejection fraction ( HFpEF
diastolic dysfunction , which is a heart relaxation abnormalitycontributesto heart failure with preserved ejection fraction ( HFpEF
oxidative stress and vascular dysfunctioncontributeto heart failure with preserved ejection fraction ( HFPEF
a heart relaxation abnormalitycontributesto heart failure with preserved ejection fraction ( HFpEF
The mechanismcausingheart failure with preserved ejection fraction ( HFPEF
NO ) availabilitymay contributeto the pathophysiology of heart failure with preserved ejection fraction
oxidative stress and vascularcontributeto heart failure with preserved ejection fraction ( HFPEF
Mechanismsleadingto symptomatic heart failure with preserved ejection fraction
Microvascular functions such as control of blood flow and inflammationcontributeto heart failure with preserved ejection fraction ( HFpEF
Cardiac fibrosis ... diastolic dysfunctioncan ... resultin heart failure with preserved ejection fraction
a diastolic dysfunctionresultingin heart failure with preserved ejection fraction
diastolic dysfunctioncan ... leadto heart failure with preserved ejection fraction
by diastolic dysfunction(passive) caused bypreserved ejection fraction Heart failure
enlargement of the left ventricle wall(passive) is caused byHeart failure with preserved ejection fraction
Stiffening of the left ventriclecontributesheart failure with preserved ejection fraction
Other devicesmay causeheart failure with preserved ejection fraction
especially thoseleadingto heart failure with preserved ejection fraction
your childmay resultin preserved ejection fraction heart disease
The addition of VEGF into the transfection cocktailresultedin a 4-fold improvement in the cardiac ejection fraction
RSK3-mAKAP signaling , a signal transduction network that is involved in cardiac remodeling ... cardiovascular diseaseresultsin heart failure with preserved ejection fraction
study(passive) was designedstudy
to an increased risk for all - cause and cardiovascular mortalityleadsto an increased risk for all - cause and cardiovascular mortality
Systolic HF(passive) is caused bySystolic HF
in exertion - limiting shortness of breath and fatigueresultingin exertion - limiting shortness of breath and fatigue
in an elevated RAPwould resultin an elevated RAP
The drug(passive) is designedThe drug
patients ' outcomesinfluencedpatients ' outcomes
in cardiac failureresultsin cardiac failure
to increasedleadingto increased
to HFpEFcontributeto HFpEF
An acute reticular pattern(passive) is most frequently caused byAn acute reticular pattern
to exercise intolerance in obesitymay contributeto exercise intolerance in obesity
to filling abnormalitiescontributesto filling abnormalities
the heart to pump out less blood than normalcausesthe heart to pump out less blood than normal
to decreased stroke volumeleadsto decreased stroke volume
lung remodeling characterized by myofibroblasts proliferation and fibrosis leading to a restrictive lung syndrome contributing to PH and RV dysfunctioncauseslung remodeling characterized by myofibroblasts proliferation and fibrosis leading to a restrictive lung syndrome contributing to PH and RV dysfunction
lung remodelling with myofibroblasts proliferation and fibrosis leading to a restrictive lung syndrome with pulmonary hypertension ( PH ) and right ventricular ( RV ) dysfunctioncauseslung remodelling with myofibroblasts proliferation and fibrosis leading to a restrictive lung syndrome with pulmonary hypertension ( PH ) and right ventricular ( RV ) dysfunction
The company 's interatrial shunt device ( IASD ) , a trans - catheter device and non - surgical medical device(passive) is designedThe company 's interatrial shunt device ( IASD ) , a trans - catheter device and non - surgical medical device
to heart failure hospitalizationscontribute equallyto heart failure hospitalizations
the balance(passive) caused bythe balance
HFpEFresultsHFpEF
after a widow maker , triple blockagediscoveredafter a widow maker , triple blockage